Viracta Therapeutics (VIRX) Institutional Ownership → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free VIRX Stock Alerts $0.81 0.00 (-0.12%) (As of 02:27 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Viracta Therapeutics (NASDAQ:VIRX)CurrentInstitutional OwnershipPercentage31.37%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$140.27KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$174.91K Get VIRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Viracta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VIRX Institutional Buying and Selling by Quarter Ad Stansberry ResearchWarren Buffett's "mystery stock"WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some Viracta Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/13/2023 Acadian Asset Management LLC97,109$99K0.0%-42.1%0.252% 8/7/2023 Acadian Asset Management LLC167,818$235K0.0%+74.6%0.436% 8/2/2023 MAI Capital Management307,570$434K0.0%-18.9%0.800% 7/20/2023 Bailard Inc.47,700$67K0.0%+139.7%0.124% 5/15/2023 Rubric Capital Management LP1,487,385$2.37M0.1%+11.8%3.872% 5/10/2023 MAI Capital Management379,468$603K0.0%-11.1%0.988% Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/8/2023 Bailard Inc.19,900$32K0.0%N/A0.052% 4/4/2023 Trust Co. of Toledo NA OH28,000$45K0.0%N/A0.073% 2/9/2023 MAI Capital Management426,916$623K0.0%-33.0%1.118% 11/14/2022Ergoteles LLC132,636$566K0.0%-14.7%0.353% 11/14/2022 Rubric Capital Management LP994,801$4.25M0.2%N/A2.649% 11/8/2022 Hamilton Lane Advisors LLC35,791$153K0.1%-49.9%0.095% 8/15/2022 Laurion Capital Management LP698,000$2.71M0.0%N/A1.858% 8/12/2022 Ensign Peak Advisors Inc63,406$246K0.0%+4.8%0.169% 7/20/2022 Clear Harbor Asset Management LLC25,000$97K0.0%N/A0.067% 7/19/2022 MAI Capital Management647,950$2.51M0.0%+70.2%1.728% 5/11/2022Veritable L.P.24,836$118K0.0%N/A0.066% 5/10/2022 MAI Capital Management380,788$1.81M0.0%N/A1.016% 2/25/2022 AlphaCentric Advisors LLC90,000$329K0.1%N/A0.241% 2/11/2022 Ensign Peak Advisors Inc60,515$221K0.0%N/A0.162% 2/8/2022 ProShare Advisors LLC13,174$49K0.0%N/A0.035% 2/8/2022 Northern Trust Corp293,492$1.07M0.0%-2.8%0.787% 1/28/2022 Allspring Global Investments Holdings LLC73,011$266K0.0%N/A0.196% 11/16/2021 Janus Henderson Group PLC249,686$2.00M0.0%-20.4%0.669% 11/16/2021 Metropolitan Life Insurance Co NY5,766$46K0.0%-48.8%0.015% 11/15/2021 Royal Bank of Canada182,319$1.46M0.0%-6.3%0.490% 11/15/2021 Franklin Resources Inc.43,618$350K0.0%N/A0.117% 11/15/2021 Jasper Ridge Partners L.P.92,939$745K0.0%N/A0.250% 11/12/2021 Jump Financial LLC21,852$175K0.0%N/A0.059% 11/12/2021 Oppenheimer & Co. Inc.38,037$305K0.0%N/A0.102% 11/12/2021 Geode Capital Management LLC481,301$3.86M0.0%+7.1%1.293% 11/10/2021 Goldman Sachs Group Inc.171,194$1.37M0.0%-34.5%0.460% 11/10/2021 Citigroup Inc.4,206$34K0.0%+109.6%0.011% 11/9/2021 Bourgeon Capital Management LLC18,750$150K0.0%+3,650.0%0.050% 11/9/2021 BlackRock Inc.2,085,048$16.72M0.0%+1.2%5.600% 11/8/2021 State Board of Administration of Florida Retirement System10,068$81K0.0%N/A0.027% 11/5/2021 Advisor Group Holdings Inc.4,999$39K0.0%N/A0.013% 11/2/2021 New York State Common Retirement Fund22,055$177K0.0%-28.9%0.059% 11/1/2021 SG Americas Securities LLC20,454$164K0.0%N/A0.055% 10/22/2021 Spire Wealth Management3,698$30K0.0%-48.1%0.010% Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some 10/14/2021 Hamilton Lane Advisors LLC71,491$573K0.1%N/A0.192% 8/17/2021 Samsara BioCapital LLC711,039$8.06M1.0%-14.5%1.917% 8/17/2021 Metropolitan Life Insurance Co NY11,260$128K0.0%N/A0.030% 8/17/2021 MetLife Investment Management LLC14,707$167K0.0%N/A0.040% 8/17/2021 Bridgeway Capital Management LLC50,000$567K0.0%N/A0.135% 8/16/2021 Opaleye Management Inc.257,189$2.92M0.5%+148.3%0.693% 8/16/2021 California State Teachers Retirement System49,982$567K0.0%N/A0.135% 8/16/2021 Kettle Hill Capital Management LLC185,065$2.10M0.4%N/A0.499% 8/16/2021 Royal Bank of Canada194,526$2.21M0.0%+9,426.2%0.524% 8/16/2021 Charles Schwab Investment Management Inc.83,792$951K0.0%N/A0.226% 8/16/2021 State Street Corp484,222$5.49M0.0%N/A1.305% 8/16/2021 Nuveen Asset Management LLC147,734$1.68M0.0%N/A0.398% 8/16/2021 Goldman Sachs Group Inc.261,513$2.97M0.0%-56.7%0.705% 8/13/2021 Northern Trust Corp313,350$3.55M0.0%+2,273.5%0.845% 8/13/2021QS Investors LLC43,618$495K0.0%N/A0.118% 8/13/2021 Geode Capital Management LLC449,236$5.09M0.0%+667.5%1.211% 8/13/2021 Vanguard Group Inc.1,433,922$16.26M0.0%+589.2%3.866% 8/13/2021 Bailard Inc.145,000$1.64M0.1%+291.9%0.391% 8/12/2021 Trexquant Investment LP10,339$117K0.0%N/A0.028% 8/12/2021 Legal & General Group Plc3,098$35K0.0%N/A0.008% 8/12/2021 JPMorgan Chase & Co.13,919$158K0.0%N/A0.038% 8/12/2021 The Manufacturers Life Insurance Company21,875$248K0.0%N/A0.059% 8/11/2021 Bank of New York Mellon Corp98,295$1.12M0.0%N/A0.265% 8/11/2021 BlackRock Inc.2,061,171$23.38M0.0%+1,006.2%5.557% 8/11/2021 Deutsche Bank AG21,524$244K0.0%N/A0.058% 8/6/2021 Ameritas Investment Partners Inc.2,843$32K0.0%N/A0.008% 8/6/2021 Nisa Investment Advisors LLC3,800$43K0.0%N/A0.010% 8/6/2021 Aisling Capital Management LP288,571$3.27M0.5%N/A0.778% 8/6/2021 Sei Investments Co.16,908$192K0.0%N/A0.046% 8/5/2021 Rhumbline Advisers30,082$341K0.0%N/A0.081% 8/2/2021 New York State Common Retirement Fund31,000$352K0.0%N/A0.084% 6/3/2021 Hoylecohen LLC14,000$130K0.0%N/A0.038% 5/19/2021 Logos Global Management LP470,000$4.35M0.4%N/A9.084% 5/18/2021 BVF Inc. IL3,094,174$28.62M1.1%N/A59.802% 5/18/2021 Millennium Management LLC123,410$1.14M0.0%N/A2.385% 5/18/2021 Opaleye Management Inc.103,600$958K0.1%N/A2.002% 5/18/2021 Samsara BioCapital LLC831,625$7.69M1.4%N/A16.073% 5/18/2021 Silverarc Capital Management LLC28,570$264K0.1%N/A0.552% 5/17/2021 Palo Alto Investors LP33,212$307K0.0%N/A0.642% 5/17/2021 Price T Rowe Associates Inc. MD510,000$4.72M0.0%N/A9.857% 5/17/2021 Janus Henderson Group PLC646,820$5.99M0.0%N/A12.501% 5/17/2021 HRT Financial LP23,826$220K0.0%N/A0.460% 5/17/2021 Ikarian Capital LLC155,599$1.44M0.0%N/A3.007% 5/17/2021 Goldman Sachs Group Inc.603,974$5.59M0.0%N/A11.673% 5/14/2021 NEA Management Company LLC37,093$343K0.0%N/A0.717% 5/14/2021 Hoylecohen LLC14,000$130K0.0%N/A0.271% 5/14/2021 Monashee Investment Management LLC84,802$784K0.1%N/A1.639% 5/14/2021 Sectoral Asset Management Inc647,556$5.99M0.5%N/A12.516% 5/13/2021 Citigroup Inc.33,594$311K0.0%N/A0.649% 5/13/2021 Blair William & Co. IL51,843$480K0.0%N/A1.002% **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report5/12/2021 Northern Trust Corp13,202$122K0.0%N/A0.255% 5/12/2021 Geode Capital Management LLC58,535$541K0.0%N/A1.131% 5/7/2021 BlackRock Inc.186,325$1.72M0.0%N/A3.601% 5/7/2021 Sowell Financial Services LLC4,285$44K0.0%N/A0.083% (Data available from 1/1/2016 forward) VIRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VIRX shares? During the previous two years, 10 institutional investors and hedge funds held shares of Viracta Therapeutics. The most heavily invested institutionals were Laurion Capital Management LP ($2.71M), Rubric Capital Management LP ($2.37M), Ergoteles LLC ($566K), MAI Capital Management ($434K), Ensign Peak Advisors Inc ($246K), Hamilton Lane Advisors LLC ($153K), and Acadian Asset Management LLC ($99K).Learn more on VIRX's institutional investors. What percentage of Viracta Therapeutics stock is owned by institutional investors? 31.37% of Viracta Therapeutics stock is owned by institutional investors. Learn more on VIRX's institutional investor holdings. Which institutional investors have been buying Viracta Therapeutics stock? The following institutional investors have purchased Viracta Therapeutics stock in the last 24 months: Rubric Capital Management LP ($1.15M), Laurion Capital Management LP ($698K), MAI Capital Management ($267.16K), Acadian Asset Management LLC ($71.68K), Bailard Inc. ($47.70K), Trust Co. of Toledo NA OH ($28K), and Clear Harbor Asset Management LLC ($25K). How much institutional buying is happening at Viracta Therapeutics? Institutional investors have bought a total of 2,291,639 shares in the last 24 months. This purchase volume represents approximately $8.57M in transactions. Which Viracta Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Viracta Therapeutics stock in the last 24 months: MAI Capital Management ($330.07K), Acadian Asset Management LLC ($70.71K), Hamilton Lane Advisors LLC ($35.70K), and Ergoteles LLC ($22.93K). How much institutional selling is happening at Viracta Therapeutics? Institutional investors have sold a total of 459,406 shares in the last 24 months. This volume of shares sold represents approximately $808.35K in transactions. Related Companies: SPRB Major Shareholders DARE Major Shareholders ACXP Major Shareholders IPA Major Shareholders FBIO Major Shareholders THTX Major Shareholders NRXP Major Shareholders BCTX Major Shareholders MRKR Major Shareholders APLM Major Shareholders This page (NASDAQ:VIRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldProtect Your Bank Account Before It’s Too LateWeiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.